Here are the vaccine options available for the third jab!
Registration for the third jab of the coronavirus vaccine starts at the beginning of August. After weeks of guessing, the National Centre for Public Health has revealed which combination of vaccines can be given to the patients.
The third jab of the coronavirus vaccine can be requested 4-6 months after the second vaccination and, for the time being, is recommended primarily for elderly, chronic patients, reported Hungarian news portal Portfolio.
As we previously reported, registration for the third jab starts from the second half of the week. According to the National Centre for Public Health,
the combination of vaccines that can be given is as follows:
- after two jabs of AstraZeneca: Pfizer, Moderna, and Sinopharm can be given as the third jab;
- after two jabs of Janssen: Pfizer, Moderna, and Sinopharm can be given;
- after two jabs of Moderna: Janssen, Sinopharm, and AstraZeneca can be given;
- after two jabs of Pfizer: Janssen, Sinopharm, and AstraZeneca can be given;
- after two jabs of Sinopharm: Pfizer, Moderna, AstraZeneca, and Janssen can be given;
- after two jabs of Sputnik: Pfizer, Moderna, and Sinopharm can be given.
As far as the two-dose vaccination is concerned, Hungary was at the forefront – behind Malta – in March with 55.80%, which is 9% higher than the EU average (46.79%) and is still a significant advantage.
According to the summary of Our World in Data, as far as single-dose vaccination is concerned, Hungary jumped to second place behind Malta at the beginning of March and remained there until the end of June. Since then, however, Hungary began to gradually slip back in the ranking while other countries moved forward. Currently, 57.98% of the total population has already received at least one vaccine in Hungary, with which the country ranks 16th among the 27 Member States. The EU average is now 57.88%, reported Hungarian news portal Telex.
Nevertheless, it is important to emphasise that similarly to other developed countries, Hungary has reached the peak of willingness to vaccinate, which can serve as an explanation as to why the vaccination program has slowed down drastically by now.
Even though there are plenty of vaccines in stock, the rest of the population is not interested and rejects the possibility of vaccination.
Still, it is worrying that many Hungarians have decided not to go for the second jab due to having received the immunity certificate after the first dose of the vaccine. This is especially true now, in the case of the Delta variant, as it is known that a single dose of the vaccine offers a lower degree of immunity against the virus than previously in the case of the Alpha variant, while after the second dose, the effectiveness is already similar. As a potential solution for the situation, it has been announced recently that the vaccination campaign for the elderly starts soon, within the framework of which medical students will personally visit elderly people who have not yet received a jab to convince them of the need for the vaccine.
Read alsoChief medical officer proposes booster jabs to fight virus variants in Hungary
Source: portfolio.hu; telex.hu
This is illogical and very disappointing. I have had two vaccinations with Sputnik V. I am aged over 50, with some underlying health conditions, and I am keen to have a 3rd vaccine. I will never accept an mRNA vaccine, so my only choice is Sinopharm (a single dose of which is so weak that it is a waste of time when you have had 2 doses of the excellent Sputnik V). There is clearly no sensible science or sound medical reasoning behind the arbitrary dictat on this. I cannot understand why I cannot have Janssen (my preference) or Astra Zeneca. My wife, who is older and has more serious conditions, is also in the same position
ASTRAZENECA – efficacy about 60% but serious (albeit rare) complications include intravascular blood-
clotting.
JANSSEN – efficacy about 65% but serious (albeit rare) complications include blood-clotting (as above)
and a major nervous system disorder (GUILLAIN-BARRE SYNDROME).
SINOPHARM – efficacy about 70% but probably lower in elderly patients.
Serious complications NOT fully known to date (and probably will NEVER be disclosed).
Even the Chinese are now starting to realise that mRNA vaccines are more effective.
RECOMMENDATION – for those individuals in Hungary already vaccinated with two doses of MODERNA or PFIZER vaccines, under NO CIRCUMSTANCES WHATSOEVER should you accept any of the above three vaccines for a ‘third ‘ (booster) injection.
Wait for the Government to offer a third mRNA vaccine as a booster – either MODERNA or PFIZER !!
I’ve had two doses of Pfizer. If I had to have a third there’s absolutely no way I am having anything other than that one. I’m going nowhere near the Sinopharm. How can they know it’s safe to mix the vaccines when Sinopharm and Sputnik are constructed completely differently. What tests have been done.